Private investment firm invests in Royal Biologics — 4 insights

Biologics

Granite Creek Capital Partners, a private investment firm in Chicago, invested in regenerative medicine company Royal Biologics.

Four insights:

1. Royal Biologics develops biologics, orthobiologics and orthopedic implants used in stem cells and other surgical procedures.

2. This is the first healthcare investment of Granite Creek's recently closed $200 million FlexCap II fund.

3. The investment will be used to expedite new hires, expand operations, increase product development and pursue acquisitions.

4. Two partners at Granite Creek — Jim Clark and Mark Radzik — will serve on the board of Royal Biologics.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers